The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Infection Prevention and Enteral Access-Global Market Insights and Sales Trends 2025
Synopsis
Enteral access is the process by which nutrition is delivered to the patient. It is usually used in hospitalized patients; in this process, liquid supplements or daily requirements are fed to the patient with the help of a tube.
The global Infection Prevention and Enteral Access market size is expected to reach US$ 2483 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029. The market is mainly driven by the significant applications of Infection Prevention and Enteral Access in various end use industries. The expanding demands from the Oncology, Gastroenterology, Diabetes and Neurological Disorders, are propelling Infection Prevention and Enteral Access market. Enteral Feeding Pumps, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Enteral Feeding Tubes segment is estimated at % CAGR for the next seven-year period.
Factors such as presence of postoperative patients with limited oral intake, increasing incidences of severe pancreatitis and chronic diseases, increasing geriatric population, technological advancements, and higher immature births drive the market growth.
Moreover, increasing RandD investments and untapped market opportunities in developing countries increase opportunities for the market growth.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infection Prevention and Enteral Access, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Infection Prevention and Enteral Access market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infection Prevention and Enteral Access market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infection Prevention and Enteral Access sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infection Prevention and Enteral Access covered in this report include Cook Medical, Medtronic Plc, Boston Scientific Corporation, CONMED Corporation, CORPAK MedSystems, CR Bard, ALCOR Scientific, Pacific Hospital Supply and Teleflexorporated, etc.
The global Infection Prevention and Enteral Access market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cook Medical
Medtronic Plc
Boston Scientific Corporation
CONMED Corporation
CORPAK MedSystems
CR Bard
ALCOR Scientific
Pacific Hospital Supply
Teleflexorporated
Vygon SA
Global Infection Prevention and Enteral Access market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infection Prevention and Enteral Access market, Segment by Type:
Enteral Feeding Pumps
Enteral Feeding Tubes
Administration Reservoirs
Giving Sets
Enteral Syringes
Global Infection Prevention and Enteral Access market, by Application
Oncology
Gastroenterology
Diabetes
Neurological Disorders
Hypermetabolism
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infection Prevention and Enteral Access companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Enteral access is the process by which nutrition is delivered to the patient. It is usually used in hospitalized patients; in this process, liquid supplements or daily requirements are fed to the patient with the help of a tube.
The global Infection Prevention and Enteral Access market size is expected to reach US$ 2483 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029. The market is mainly driven by the significant applications of Infection Prevention and Enteral Access in various end use industries. The expanding demands from the Oncology, Gastroenterology, Diabetes and Neurological Disorders, are propelling Infection Prevention and Enteral Access market. Enteral Feeding Pumps, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Enteral Feeding Tubes segment is estimated at % CAGR for the next seven-year period.
Factors such as presence of postoperative patients with limited oral intake, increasing incidences of severe pancreatitis and chronic diseases, increasing geriatric population, technological advancements, and higher immature births drive the market growth.
Moreover, increasing RandD investments and untapped market opportunities in developing countries increase opportunities for the market growth.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infection Prevention and Enteral Access, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Infection Prevention and Enteral Access market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infection Prevention and Enteral Access market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infection Prevention and Enteral Access sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infection Prevention and Enteral Access covered in this report include Cook Medical, Medtronic Plc, Boston Scientific Corporation, CONMED Corporation, CORPAK MedSystems, CR Bard, ALCOR Scientific, Pacific Hospital Supply and Teleflexorporated, etc.
The global Infection Prevention and Enteral Access market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cook Medical
Medtronic Plc
Boston Scientific Corporation
CONMED Corporation
CORPAK MedSystems
CR Bard
ALCOR Scientific
Pacific Hospital Supply
Teleflexorporated
Vygon SA
Global Infection Prevention and Enteral Access market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infection Prevention and Enteral Access market, Segment by Type:
Enteral Feeding Pumps
Enteral Feeding Tubes
Administration Reservoirs
Giving Sets
Enteral Syringes
Global Infection Prevention and Enteral Access market, by Application
Oncology
Gastroenterology
Diabetes
Neurological Disorders
Hypermetabolism
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infection Prevention and Enteral Access companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Infection Prevention and Enteral Access
1.1 Infection Prevention and Enteral Access Market Overview
1.1.1 Infection Prevention and Enteral Access Product Scope
1.1.2 Infection Prevention and Enteral Access Market Status and Outlook
1.2 Global Infection Prevention and Enteral Access Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Infection Prevention and Enteral Access Market Size by Region (2018-2029)
1.4 Global Infection Prevention and Enteral Access Historic Market Size by Region (2018-2023)
1.5 Global Infection Prevention and Enteral Access Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Infection Prevention and Enteral Access Market Size (2018-2029)
1.6.1 North America Infection Prevention and Enteral Access Market Size (2018-2029)
1.6.2 Europe Infection Prevention and Enteral Access Market Size (2018-2029)
1.6.3 Asia-Pacific Infection Prevention and Enteral Access Market Size (2018-2029)
1.6.4 Latin America Infection Prevention and Enteral Access Market Size (2018-2029)
1.6.5 Middle East & Africa Infection Prevention and Enteral Access Market Size (2018-2029)
2 Infection Prevention and Enteral Access Market by Type
2.1 Introduction
2.1.1 Enteral Feeding Pumps
2.1.2 Enteral Feeding Tubes
2.1.3 Administration Reservoirs
2.1.4 Giving Sets
2.1.5 Enteral Syringes
2.2 Global Infection Prevention and Enteral Access Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Infection Prevention and Enteral Access Historic Market Size by Type (2018-2023)
2.2.2 Global Infection Prevention and Enteral Access Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Infection Prevention and Enteral Access Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Infection Prevention and Enteral Access Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Infection Prevention and Enteral Access Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Infection Prevention and Enteral Access Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Infection Prevention and Enteral Access Revenue Breakdown by Type (2018-2029)
3 Infection Prevention and Enteral Access Market Overview by Application
3.1 Introduction
3.1.1 Oncology
3.1.2 Gastroenterology
3.1.3 Diabetes
3.1.4 Neurological Disorders
3.1.5 Hypermetabolism
3.1.6 Others
3.2 Global Infection Prevention and Enteral Access Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Infection Prevention and Enteral Access Historic Market Size by Application (2018-2023)
3.2.2 Global Infection Prevention and Enteral Access Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Infection Prevention and Enteral Access Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Infection Prevention and Enteral Access Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Infection Prevention and Enteral Access Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Infection Prevention and Enteral Access Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Infection Prevention and Enteral Access Revenue Breakdown by Application (2018-2029)
4 Infection Prevention and Enteral Access Competition Analysis by Players
4.1 Global Infection Prevention and Enteral Access Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infection Prevention and Enteral Access as of 2022)
4.3 Date of Key Players Enter into Infection Prevention and Enteral Access Market
4.4 Global Top Players Infection Prevention and Enteral Access Headquarters and Area Served
4.5 Key Players Infection Prevention and Enteral Access Product Solution and Service
4.6 Competitive Status
4.6.1 Infection Prevention and Enteral Access Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Cook Medical
5.1.1 Cook Medical Profile
5.1.2 Cook Medical Main Business
5.1.3 Cook Medical Infection Prevention and Enteral Access Products, Services and Solutions
5.1.4 Cook Medical Infection Prevention and Enteral Access Revenue (US$ Million) & (2018-2023)
5.1.5 Cook Medical Recent Developments
5.2 Medtronic Plc
5.2.1 Medtronic Plc Profile
5.2.2 Medtronic Plc Main Business
5.2.3 Medtronic Plc Infection Prevention and Enteral Access Products, Services and Solutions
5.2.4 Medtronic Plc Infection Prevention and Enteral Access Revenue (US$ Million) & (2018-2023)
5.2.5 Medtronic Plc Recent Developments
5.3 Boston Scientific Corporation
5.3.1 Boston Scientific Corporation Profile
5.3.2 Boston Scientific Corporation Main Business
5.3.3 Boston Scientific Corporation Infection Prevention and Enteral Access Products, Services and Solutions
5.3.4 Boston Scientific Corporation Infection Prevention and Enteral Access Revenue (US$ Million) & (2018-2023)
5.3.5 CONMED Corporation Recent Developments
5.4 CONMED Corporation
5.4.1 CONMED Corporation Profile
5.4.2 CONMED Corporation Main Business
5.4.3 CONMED Corporation Infection Prevention and Enteral Access Products, Services and Solutions
5.4.4 CONMED Corporation Infection Prevention and Enteral Access Revenue (US$ Million) & (2018-2023)
5.4.5 CONMED Corporation Recent Developments
5.5 CORPAK MedSystems
5.5.1 CORPAK MedSystems Profile
5.5.2 CORPAK MedSystems Main Business
5.5.3 CORPAK MedSystems Infection Prevention and Enteral Access Products, Services and Solutions
5.5.4 CORPAK MedSystems Infection Prevention and Enteral Access Revenue (US$ Million) & (2018-2023)
5.5.5 CORPAK MedSystems Recent Developments
5.6 CR Bard
5.6.1 CR Bard Profile
5.6.2 CR Bard Main Business
5.6.3 CR Bard Infection Prevention and Enteral Access Products, Services and Solutions
5.6.4 CR Bard Infection Prevention and Enteral Access Revenue (US$ Million) & (2018-2023)
5.6.5 CR Bard Recent Developments
5.7 ALCOR Scientific
5.7.1 ALCOR Scientific Profile
5.7.2 ALCOR Scientific Main Business
5.7.3 ALCOR Scientific Infection Prevention and Enteral Access Products, Services and Solutions
5.7.4 ALCOR Scientific Infection Prevention and Enteral Access Revenue (US$ Million) & (2018-2023)
5.7.5 ALCOR Scientific Recent Developments
5.8 Pacific Hospital Supply
5.8.1 Pacific Hospital Supply Profile
5.8.2 Pacific Hospital Supply Main Business
5.8.3 Pacific Hospital Supply Infection Prevention and Enteral Access Products, Services and Solutions
5.8.4 Pacific Hospital Supply Infection Prevention and Enteral Access Revenue (US$ Million) & (2018-2023)
5.8.5 Pacific Hospital Supply Recent Developments
5.9 Teleflexorporated
5.9.1 Teleflexorporated Profile
5.9.2 Teleflexorporated Main Business
5.9.3 Teleflexorporated Infection Prevention and Enteral Access Products, Services and Solutions
5.9.4 Teleflexorporated Infection Prevention and Enteral Access Revenue (US$ Million) & (2018-2023)
5.9.5 Teleflexorporated Recent Developments
5.10 Vygon SA
5.10.1 Vygon SA Profile
5.10.2 Vygon SA Main Business
5.10.3 Vygon SA Infection Prevention and Enteral Access Products, Services and Solutions
5.10.4 Vygon SA Infection Prevention and Enteral Access Revenue (US$ Million) & (2018-2023)
5.10.5 Vygon SA Recent Developments
6 North America
6.1 North America Infection Prevention and Enteral Access Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Infection Prevention and Enteral Access Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Infection Prevention and Enteral Access Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Infection Prevention and Enteral Access Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Infection Prevention and Enteral Access Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Infection Prevention and Enteral Access Market Dynamics
11.1 Infection Prevention and Enteral Access Industry Trends
11.2 Infection Prevention and Enteral Access Market Drivers
11.3 Infection Prevention and Enteral Access Market Challenges
11.4 Infection Prevention and Enteral Access Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
